Pharma M&A Integration Architecture
An anonymized Larkinized engagement illustrating EA value in healthcare.
Client Context
A pharma company integrating R&D and commercial IT after acquisition. Larkinized engaged with CIO and business sponsors across healthcare.
Challenge
Duplicate LIMS and CRM; GxP validation boundaries unclear.
Approach
Integration architecture with validated interfaces; phased harmonization of master data.
Architecture Decisions
GxP segregation; API gateway for partner data; single product master roadmap.
Outcomes
Integration defects down; faster synergy capture; FDA audit readiness improved.
Lessons Learned
M&A architecture must label GxP scope before cutting systems.
Need Expert Guidance?
Larkinized LLC helps organizations design, govern, and execute enterprise architecture programs that deliver measurable business outcomes.